3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Ovarian Neoplasms
26
Small Cell Lung Carcinoma
22
Neuroblastoma
12
Fallopian Tube Neoplasms
12
Uterine Cervical Neoplasms
8
Carcinoma, Ovarian Epithelial
8
Lung Neoplasms
7
Neoplasm Metastasis
5
Carcinoma, Non-Small-Cell Lung
4
Leukemia, Myeloid, Acute
3
Ganglioneuroblastoma
3
Brain Neoplasms
3
Sarcoma
2
Recurrence
2
Neuroectodermal Tumors, Primitive, Peripheral
2
Neoplasms
2
Hereditary Sensory and Autonomic Neuropathies
2
Gliosarcoma
2
Glioblastoma
2
Central Nervous System Neoplasms
2
Carcinoma, Small Cell
2
Carcinoma, Neuroendocrine
2
Thrombocythemia, Essential
1
Sarcoma, Ewing
1
Rhabdoid Tumor
1
Retinoblastoma
1
Retinal Neoplasms
1
Primary Myelofibrosis
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Polycythemia Vera
1
Interventions
Magnetic Resonance Spectroscopy
2
Everolimus
2
Erlotinib Hydrochloride
2
ribociclib
1
palbociclib
1
olaparib
1
etoposide phosphate
1
erdafitinib
1
X-Rays
1
Sunitinib
1
Specimen Handling
1
Radiotherapy
1
Phantoms, Imaging
1
Nuclear Medicine Department, Hospital
1
N-(3-chloro-4-((3-fluorobenzyl)oxy)phenyl-6-(5-((methylsulfonyl)ethyl)aminomethyl)-2-furyl)-4-quinazolinamine
1
Microarray Analysis
1
Lapatinib
1
Irinotecan
1
Immunologic Techniques
1
Immunohistochemistry
1
Immunoglobulin G
1
Ifosfamide
1
Fluorodeoxyglucose F18
1
Etoposide
1
Donepezil
1
Disulfides
1
Dasatinib
1
Cyproheptadine
1
Carboplatin
1
Blotting, Western
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Familial ependymoma
×
Topotecan
×
Clear all
No trials found.